Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity

v3.25.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Beginning balance (shares) at Dec. 31, 2023   24,850,261      
Beginning balance at Dec. 31, 2023 $ 14,652,295 $ 24,850 $ 57,601,402 $ (42,879,656) $ (94,301)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock based compensation expense 89,998   89,998    
Distributions to non-controlling interest (48,654)       (48,654)
Net (loss) income (2,598,092)     (2,643,763) 45,671
Ending balance (shares) at Jun. 30, 2024   24,850,261      
Ending balance at Jun. 30, 2024 12,095,547 $ 24,850 57,691,400 (45,523,419) (97,284)
Beginning balance (shares) at Mar. 31, 2024   24,850,261      
Beginning balance at Mar. 31, 2024 13,609,213 $ 24,850 57,645,936 (43,984,623) (76,950)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock based compensation expense 45,464   45,464    
Distributions to non-controlling interest (48,654)       (48,654)
Net (loss) income (1,510,476)     (1,538,796) 28,320
Ending balance (shares) at Jun. 30, 2024   24,850,261      
Ending balance at Jun. 30, 2024 12,095,547 $ 24,850 57,691,400 (45,523,419) (97,284)
Beginning balance (shares) at Dec. 31, 2024   24,950,261      
Beginning balance at Dec. 31, 2024 $ 10,125,538 $ 24,950 57,845,289 (47,639,894) (104,807)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (shares) 380,973 380,973      
Exercise of stock options $ 394,926 $ 381 394,545    
Related party note conversion to common stock (in shares)   240,256      
Related party note conversion to common stock 514,148 $ 240 513,908    
Stock based compensation expense 83,439   83,439    
Distributions to non-controlling interest (42,956)       (42,956)
Net (loss) income (2,133,644)     (2,124,027) (9,617)
Ending balance (shares) at Jun. 30, 2025   25,571,490      
Ending balance at Jun. 30, 2025 8,941,451 $ 25,571 58,837,181 (49,763,921) (157,380)
Beginning balance (shares) at Mar. 31, 2025   24,985,261      
Beginning balance at Mar. 31, 2025 9,511,493 $ 24,985 57,924,587 (48,299,816) (138,263)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (shares)   345,973      
Exercise of stock options 356,426 $ 346 356,080    
Related party note conversion to common stock (in shares)   240,256      
Related party note conversion to common stock 514,148 $ 240 513,908    
Stock based compensation expense 42,606   42,606    
Distributions to non-controlling interest (10,067)       (10,067)
Net (loss) income (1,473,155)     (1,464,105) (9,050)
Ending balance (shares) at Jun. 30, 2025   25,571,490      
Ending balance at Jun. 30, 2025 $ 8,941,451 $ 25,571 $ 58,837,181 $ (49,763,921) $ (157,380)